Orthopediatrics (KIDS) Gross Margin (2016 - 2026)
Orthopediatrics' (KIDS) quarterly Gross Margin came in at 73.09% in Q1 2026, up 9.0% year-on-year from 67.06% in Q1 2025, and little changed on a QoQ basis from 73.22% in Q4 2025.
Orthopediatrics (KIDS) Gross Margin (2016 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has 11 years of Gross Margin data on file, last reported at 73.09% in Q1 2026.
- On a quarterly basis, Gross Margin rose 9.0% year-over-year to 73.09% in Q1 2026; TTM through Mar 2026 was 73.07%, a 26.0% increase from a year earlier, with the FY2025 full-year figure at 73.05%, up 47.0% from the prior year.
- Gross Margin for Q1 2026 stood at 73.09%, roughly flat from 73.22% in the prior quarter.
- Over the last five years, Gross Margin for KIDS reached as high as 79.28% in Q1 2022 and fell as low as 67.53% in Q4 2024.
- Historically, Gross Margin has averaged 73.66% across 5 years, with a median of 73.41% in 2024.
- On a YoY basis, Gross Margin climbed as much as 569 bps in 2025 and fell as far as 520 bps in 2025.
- Year by year, Gross Margin stood at 68.48% in 2022, then grew by 4 bps to 71.02% in 2023, then decreased by 5 bps to 67.53% in 2024, then grew by 8 bps to 73.22% in 2025, then slipped by 0 bps to 73.09% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 73.09% in Q1 2026, 73.22% in Q4 2025, and 73.92% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Orthopediatrics | 443.38 Mn | 429.14 Mn | 43.39 Mn | 73.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.09% |
| Dec 31, 2025 | 73.22% |
| Sep 30, 2025 | 73.92% |
| Jun 30, 2025 | 72.07% |
| Mar 31, 2025 | 73.00% |
| Dec 31, 2024 | 67.53% |
| Sep 30, 2024 | 73.41% |
| Jun 30, 2024 | 77.27% |
| Mar 31, 2024 | 72.00% |
| Dec 31, 2023 | 71.02% |
| Sep 30, 2023 | 77.44% |
| Jun 30, 2023 | 75.90% |
| Mar 31, 2023 | 74.59% |
| Dec 31, 2022 | 68.48% |
| Sep 30, 2022 | 74.07% |
| Jun 30, 2022 | 75.87% |
| Mar 31, 2022 | 79.28% |
| Dec 31, 2021 | 72.87% |
| Sep 30, 2021 | 73.98% |
| Jun 30, 2021 | 76.58% |